Stock Ratings / Health Care / RMD / dividends

LLY (72) JNJ (66) ABBV (71) UNH (70) ⌘ Pro Terminal →

ResMed Inc. (RMD) Dividend Safety Gauge & 10-Year DRIP Compounder

$252.83 +1.06% NYSE • Public Delayed / 60s Snapshot

ResMed Inc. (RMD) earns a Roarable Rating of B (Buy) with 74/100 RQD Confidence. High-quality cash engine (59% profit margin, 23% return on capital) with steady institutional support. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.

ROARABLE B • BUY Cap $35.56B

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERBUY • B

2-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

5-PILLAR SNOWFLAKE RADARRw C+ · Rk A-

Each axis scored 0–20

12M PRICE TARGET CONE+7.2% Base Target

WHALE OPTIONS TUG-OF-WAR:56% Call Buyers ($3.6M)

44% PutsMax Pain: $248.00

CASH DIVIDEND + BUYBACK YIELD

2.67% Total Yield

0.87% Cash ($2.20/yr) + 1.8% Buybacks

PAYOUT SAFETY SPEEDOMETER

88/100 • FORTRESS PAYOUT

FREE CASH FLOW PAYOUT RATIO

14% of FCF

8 consecutive years of payout growth

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (8.1% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $21,790

Est. Year-10 Shareholder Yield: $582/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$10.8K

Yr 1

$11.7K

Yr 2

$12.6K

Yr 3

$13.7K

Yr 4

$14.8K

Yr 5

$16.0K

Yr 6

$17.2K

Yr 7

$18.6K

Yr 8

$20.2K

Yr 9

$21.8K

Yr 10

🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher + Senior Cash-Flow & Income Strategist

Cash-Fortress Compounders: Collecting Safe Yield & Upside in RMD & Top A-Rated Leaders

✓12-month Bull/Base/Bear fair-value walkthrough on RMD and its top sector rival
✓The Top 5 Roarable A-Rated cash compounders with heavy executive & 13F accumulation
✓Includes free daily Morning Market Weather & signal upgrade/downgrade dispatch

RQD INSIDER CLUB UPGRADE$49/YEAR

Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?

🤖 Try AI Indicator Builder ($49/yr VIP) →$100K Arena

RMD // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +7.54%🛡️ HOLDING TREND SUPPORT

2026-10-30O $246.6H $248.1L $228.3C $229.9VOL 3.45M

RES: $257.3SUP: $226.3SMA50: $231.8SMA200: $224.9

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

RMD Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 RMD Butterfly Map → + Track RMD →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

19.1%/yr Implied 5Y Growth

vs. +9.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on RMD today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

LLY → RMD Analyst Hypothesis

FDA approval of Zepbound (tirzepatide) for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity introduces the first pharmacologic disease-modifying competitor to ResMed CPAP devices.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for RMD today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

RMD Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Does RMD pay a dividend and is it safe?

ResMed Inc. (RMD) offers a 0.87% cash dividend yield ($2.20 annualized) and 2.67% total shareholder yield including buybacks. Roarable rates its payout coverage as FORTRESS PAYOUT.

Direct Sub-Reports: RMD RQD Cockpit RMD 12M Forecast RMD Earnings & Move RMD Dividends & DRIP RMD Insiders & 13F RMD Whale Options RMD Profit Sankey RMD News & Why